Forecasted to grow at a CAGR of 8.9%, the global erectile dysfunction drugs market is expected to rise from US$2.8 billion in 2024 to US$4.8 billion by 2030. Key growth drivers include aging populations, greater awareness and acceptance of ED treatments, and medical technology advancements. The availability of affordable generic medications has further propelled market growth....